ADMS - Adamas Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

Adamas Pharmaceuticals's activity chart (see below) currently has 72 price targets and 64 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 39.96% of the time, taking 163.62 days on average.

Most recent stock forecast was given by from NORTHLAND CAPITAL MARKETS on 18-Nov-2021. First documented stock forecast 05-May-2014.

Best performing analysts who are covering ADMS - Adamas Pharmaceuticals:

Serge Belanger Jason Butler Tim Lugo David Amsellem Irina Koffler

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 29-Nov-2017

$8.5

5 years 1 days ago
(18-Nov-2021)

0/3 (0%)

$0.33 (4.04%)

Buy Since 17-Aug-2017

5 years 1 months 6 days ago
(13-Oct-2021)

3/7 (42.86%)

$9.25 (194.74%)

87

Hold Since 13-Oct-2021

$8

$10

5 years 1 months 6 days ago
(13-Oct-2021)

1/7 (14.29%)

$-0.07 (-0.87%)

6

Buy Since 12-Jan-2016

$8

$7

5 years 1 months 6 days ago
(13-Oct-2021)

4/5 (80%)

$-0.07 (-0.87%)

95

Buy Since 12-Nov-2018

$8

$20

5 years 1 months 7 days ago
(12-Oct-2021)

1/2 (50%)

$-0.08 (-0.99%)

7

Show more analysts

Please expand the browser size to see the chart

What is ADMS (Adamas Pharmaceuticals) average time for price targets to be met?

On average it took 164 days for the stock forecasts to be reached, with an average price target met ratio of 39.96%.

Which analyst most recently updated their price target on ADMS (Adamas Pharmaceuticals)?

Which analyst has the most public recommendations on ADMS (Adamas Pharmaceuticals)?

has 0 price targets and 0 ratings on ADMS

Which analyst is the currently most bullish on ADMS (Adamas Pharmaceuticals)?

Tazeen Ahmad with the highest potential upside of $16.78

Which analyst is the currently most reserved on ADMS (Adamas Pharmaceuticals)?

Irina Koffler with the lowest potential downside of -$3.22
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?